

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.65775720 |
| 2 | myelination (GO:0042552) | 6.48962680 |
| 3 | axon ensheathment (GO:0008366) | 6.47949222 |
| 4 | ensheathment of neurons (GO:0007272) | 6.47949222 |
| 5 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.43079744 |
| 6 | plasma lipoprotein particle assembly (GO:0034377) | 6.33152774 |
| 7 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.27704950 |
| 8 | protein-lipid complex assembly (GO:0065005) | 5.83694415 |
| 9 | protein carboxylation (GO:0018214) | 5.74059938 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.74059938 |
| 11 | negative regulation of fibrinolysis (GO:0051918) | 5.68571831 |
| 12 | low-density lipoprotein particle remodeling (GO:0034374) | 5.52864877 |
| 13 | regulation of cholesterol esterification (GO:0010872) | 5.36554920 |
| 14 | myelin maintenance (GO:0043217) | 5.24414996 |
| 15 | intestinal cholesterol absorption (GO:0030299) | 5.21904477 |
| 16 | regulation of cholesterol homeostasis (GO:2000188) | 5.21634257 |
| 17 | intestinal absorption (GO:0050892) | 5.20185566 |
| 18 | plasma lipoprotein particle remodeling (GO:0034369) | 5.16536607 |
| 19 | protein-lipid complex remodeling (GO:0034368) | 5.16536607 |
| 20 | macromolecular complex remodeling (GO:0034367) | 5.16536607 |
| 21 | cholesterol efflux (GO:0033344) | 5.02233720 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 4.93827367 |
| 23 | regulation of fibrinolysis (GO:0051917) | 4.89284114 |
| 24 | plasma lipoprotein particle organization (GO:0071827) | 4.88924203 |
| 25 | establishment of mitochondrion localization (GO:0051654) | 4.77891525 |
| 26 | protein-lipid complex subunit organization (GO:0071825) | 4.70688041 |
| 27 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.61832000 |
| 28 | negative regulation of neurotransmitter transport (GO:0051589) | 4.61081593 |
| 29 | negative regulation of protein localization to cell surface (GO:2000009) | 4.58142581 |
| 30 | reverse cholesterol transport (GO:0043691) | 4.51733508 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.49621032 |
| 32 | creatine metabolic process (GO:0006600) | 4.42986215 |
| 33 | oligodendrocyte differentiation (GO:0048709) | 4.41757709 |
| 34 | regulation of apoptotic cell clearance (GO:2000425) | 4.40253800 |
| 35 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.40054384 |
| 36 | regulation of complement activation (GO:0030449) | 4.39060296 |
| 37 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.35580517 |
| 38 | regulation of collateral sprouting (GO:0048670) | 4.35037687 |
| 39 | plasma lipoprotein particle clearance (GO:0034381) | 4.32012718 |
| 40 | cholesterol biosynthetic process (GO:0006695) | 4.17542326 |
| 41 | presynaptic membrane organization (GO:0097090) | 4.12410634 |
| 42 | regulation of plasminogen activation (GO:0010755) | 4.10515648 |
| 43 | glycerophospholipid catabolic process (GO:0046475) | 4.10144987 |
| 44 | response to methylmercury (GO:0051597) | 4.06483065 |
| 45 | eye photoreceptor cell differentiation (GO:0001754) | 4.03944015 |
| 46 | photoreceptor cell differentiation (GO:0046530) | 4.03944015 |
| 47 | diacylglycerol metabolic process (GO:0046339) | 4.03895764 |
| 48 | apical protein localization (GO:0045176) | 4.02029337 |
| 49 | L-amino acid import (GO:0043092) | 4.01618086 |
| 50 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.98415090 |
| 51 | asymmetric protein localization (GO:0008105) | 3.86799042 |
| 52 | amyloid precursor protein metabolic process (GO:0042982) | 3.84633264 |
| 53 | response to redox state (GO:0051775) | 3.77665815 |
| 54 | sterol biosynthetic process (GO:0016126) | 3.73777151 |
| 55 | L-phenylalanine metabolic process (GO:0006558) | 3.72235988 |
| 56 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.72235988 |
| 57 | phospholipid efflux (GO:0033700) | 3.71850450 |
| 58 | presynaptic membrane assembly (GO:0097105) | 3.69434066 |
| 59 | substantia nigra development (GO:0021762) | 3.67462005 |
| 60 | astrocyte development (GO:0014002) | 3.66605605 |
| 61 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.66233375 |
| 62 | low-density lipoprotein particle clearance (GO:0034383) | 3.66208160 |
| 63 | blood coagulation, intrinsic pathway (GO:0007597) | 3.65338273 |
| 64 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.64147152 |
| 65 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62941097 |
| 66 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62941097 |
| 67 | negative regulation of sterol transport (GO:0032372) | 3.59899405 |
| 68 | negative regulation of cholesterol transport (GO:0032375) | 3.59899405 |
| 69 | membrane tubulation (GO:0097320) | 3.58910274 |
| 70 | neuron cell-cell adhesion (GO:0007158) | 3.55280237 |
| 71 | lipoprotein metabolic process (GO:0042157) | 3.49752086 |
| 72 | positive regulation of extracellular matrix organization (GO:1903055) | 3.46113157 |
| 73 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.42566005 |
| 74 | regulation of bile acid biosynthetic process (GO:0070857) | 3.41160325 |
| 75 | cholesterol homeostasis (GO:0042632) | 3.40854658 |
| 76 | protein neddylation (GO:0045116) | 3.40219995 |
| 77 | positive regulation of steroid metabolic process (GO:0045940) | 3.39738362 |
| 78 | adult walking behavior (GO:0007628) | 3.37790037 |
| 79 | import into cell (GO:0098657) | 3.37490728 |
| 80 | response to lipoprotein particle (GO:0055094) | 3.37393672 |
| 81 | sterol homeostasis (GO:0055092) | 3.36564263 |
| 82 | isoprenoid biosynthetic process (GO:0008299) | 3.36149995 |
| 83 | proline metabolic process (GO:0006560) | 3.33737544 |
| 84 | protein palmitoylation (GO:0018345) | 3.33151414 |
| 85 | negative regulation of protein activation cascade (GO:2000258) | 3.31911407 |
| 86 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.29540421 |
| 87 | sterol transport (GO:0015918) | 3.27169280 |
| 88 | cholesterol transport (GO:0030301) | 3.27169280 |
| 89 | axon development (GO:0061564) | 3.22469788 |
| 90 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.21349284 |
| 91 | regulation of cholesterol metabolic process (GO:0090181) | 3.17987564 |
| 92 | virion attachment to host cell (GO:0019062) | 3.15091432 |
| 93 | adhesion of symbiont to host cell (GO:0044650) | 3.15091432 |
| 94 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.14840081 |
| 95 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.14450791 |
| 96 | regulation of extracellular matrix organization (GO:1903053) | 3.11181985 |
| 97 | lung epithelium development (GO:0060428) | 3.09236840 |
| 98 | regulation of lipoprotein metabolic process (GO:0050746) | 3.07192768 |
| 99 | neurotransmitter uptake (GO:0001504) | 3.06566731 |
| 100 | ethanol oxidation (GO:0006069) | 3.05041120 |
| 101 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.04233320 |
| 102 | glycosylceramide metabolic process (GO:0006677) | 3.03423419 |
| 103 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.02399634 |
| 104 | regulation of extracellular matrix disassembly (GO:0010715) | 3.01849783 |
| 105 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.00757667 |
| 106 | acylglycerol homeostasis (GO:0055090) | 3.00408413 |
| 107 | triglyceride homeostasis (GO:0070328) | 3.00408413 |
| 108 | limb bud formation (GO:0060174) | 2.99071813 |
| 109 | negative regulation of lipase activity (GO:0060192) | 2.98720848 |
| 110 | complement activation, alternative pathway (GO:0006957) | 2.98198751 |
| 111 | neuronal action potential propagation (GO:0019227) | 2.97165392 |
| 112 | glutamate metabolic process (GO:0006536) | 2.96939296 |
| 113 | acylglycerol catabolic process (GO:0046464) | 2.96913801 |
| 114 | neutral lipid catabolic process (GO:0046461) | 2.96913801 |
| 115 | proline biosynthetic process (GO:0006561) | 2.93223565 |
| 116 | amino acid import (GO:0043090) | 2.93171854 |
| 117 | negative regulation of JUN kinase activity (GO:0043508) | 2.91492712 |
| 118 | very long-chain fatty acid metabolic process (GO:0000038) | 2.90575603 |
| 119 | sulfate transmembrane transport (GO:1902358) | 2.89995218 |
| 120 | negative regulation of axonogenesis (GO:0050771) | 2.88701352 |
| 121 | acute-phase response (GO:0006953) | 2.88644994 |
| 122 | magnesium ion transport (GO:0015693) | 2.87404109 |
| 123 | lipid homeostasis (GO:0055088) | 2.86889103 |
| 124 | transmission of nerve impulse (GO:0019226) | 2.86632118 |
| 125 | enteric nervous system development (GO:0048484) | 2.86339443 |
| 126 | amyloid precursor protein catabolic process (GO:0042987) | 2.83481023 |
| 127 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.83470643 |
| 128 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.83470643 |
| 129 | nephron tubule morphogenesis (GO:0072078) | 2.82853478 |
| 130 | nephron epithelium morphogenesis (GO:0072088) | 2.82853478 |
| 131 | negative regulation of macroautophagy (GO:0016242) | 2.80393323 |
| 132 | vitamin transmembrane transport (GO:0035461) | 2.80362467 |
| 133 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.79195039 |
| 134 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.78425578 |
| 135 | positive regulation of synapse maturation (GO:0090129) | 2.78249432 |
| 136 | peptidyl-cysteine modification (GO:0018198) | 2.78079766 |
| 137 | myelination in peripheral nervous system (GO:0022011) | 2.77738960 |
| 138 | peripheral nervous system axon ensheathment (GO:0032292) | 2.77738960 |
| 139 | cellular zinc ion homeostasis (GO:0006882) | 2.75801387 |
| 140 | negative regulation of blood coagulation (GO:0030195) | 2.75472665 |
| 141 | negative regulation of hemostasis (GO:1900047) | 2.75472665 |
| 142 | transepithelial transport (GO:0070633) | 2.73588958 |
| 143 | negative regulation of digestive system process (GO:0060457) | 2.73471005 |
| 144 | neuron remodeling (GO:0016322) | 2.73322434 |
| 145 | drinking behavior (GO:0042756) | 2.73011785 |
| 146 | positive regulation of lipid catabolic process (GO:0050996) | 2.72141251 |
| 147 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.71625781 |
| 148 | nucleotide transmembrane transport (GO:1901679) | 2.71130787 |
| 149 | regulation of cholesterol storage (GO:0010885) | 2.70747679 |
| 150 | lipoprotein transport (GO:0042953) | 2.67771407 |
| 151 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.67742651 |
| 152 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.67157011 |
| 153 | protein activation cascade (GO:0072376) | 2.66711383 |
| 154 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.66443425 |
| 155 | negative regulation of complement activation (GO:0045916) | 2.66353790 |
| 156 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.66143366 |
| 157 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.66143366 |
| 158 | endocrine process (GO:0050886) | 2.66143366 |
| 159 | cellular response to epinephrine stimulus (GO:0071872) | 2.65803888 |
| 160 | negative regulation of sodium ion transport (GO:0010766) | 2.65778127 |
| 161 | positive regulation of action potential (GO:0045760) | 2.63828582 |
| 162 | angiotensin maturation (GO:0002003) | 2.63679128 |
| 163 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.63317938 |
| 164 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.62904563 |
| 165 | glial cell development (GO:0021782) | 2.62487120 |
| 166 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.62027103 |
| 167 | receptor catabolic process (GO:0032801) | 2.61566468 |
| 168 | negative regulation of acute inflammatory response (GO:0002674) | 2.60676064 |
| 169 | regulation of dopamine metabolic process (GO:0042053) | 2.60528141 |
| 170 | regulation of catecholamine metabolic process (GO:0042069) | 2.60528141 |
| 171 | microtubule polymerization or depolymerization (GO:0031109) | 2.60199002 |
| 172 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.60050856 |
| 173 | response to lead ion (GO:0010288) | 2.60048336 |
| 174 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.56739907 |
| 175 | trivalent inorganic anion homeostasis (GO:0072506) | 2.55571607 |
| 176 | phosphate ion homeostasis (GO:0055062) | 2.55571607 |
| 177 | positive regulation of blood coagulation (GO:0030194) | 2.55094234 |
| 178 | positive regulation of hemostasis (GO:1900048) | 2.55094234 |
| 179 | NADH metabolic process (GO:0006734) | 2.54975009 |
| 180 | glutathione biosynthetic process (GO:0006750) | 2.53006151 |
| 181 | dopamine biosynthetic process (GO:0042416) | 2.52063204 |
| 182 | positive regulation of glial cell differentiation (GO:0045687) | 2.51528961 |
| 183 | peripheral nervous system development (GO:0007422) | 2.51196444 |
| 184 | * GPI anchor metabolic process (GO:0006505) | 2.49763788 |
| 185 | neural nucleus development (GO:0048857) | 2.48187379 |
| 186 | regulation of interleukin-13 production (GO:0032656) | 2.46254611 |
| 187 | membrane raft organization (GO:0031579) | 2.46101133 |
| 188 | nerve growth factor signaling pathway (GO:0038180) | 2.45499301 |
| 189 | * GPI anchor biosynthetic process (GO:0006506) | 2.45085242 |
| 190 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.44796698 |
| 191 | L-phenylalanine catabolic process (GO:0006559) | 2.44796698 |
| 192 | iron coordination entity transport (GO:1901678) | 2.43350702 |
| 193 | negative regulation of chemokine production (GO:0032682) | 2.41692080 |
| 194 | thioester biosynthetic process (GO:0035384) | 2.41225170 |
| 195 | acyl-CoA biosynthetic process (GO:0071616) | 2.41225170 |
| 196 | cranial nerve development (GO:0021545) | 2.40982034 |
| 197 | central nervous system myelination (GO:0022010) | 11.5950953 |
| 198 | axon ensheathment in central nervous system (GO:0032291) | 11.5950953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.85511754 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.70733869 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.66679159 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.59918932 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.44529568 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.25089158 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.96142380 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.87045404 |
| 9 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.80114211 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.76570447 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.71041611 |
| 12 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.66906647 |
| 13 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.59113795 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.53998311 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.45381593 |
| 16 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.45348998 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.38726863 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.37116768 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.36153137 |
| 20 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.35024886 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.30071615 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.22952991 |
| 23 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.22023580 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.14716271 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.07728702 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.04595941 |
| 27 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.03259541 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.01917126 |
| 29 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.01917126 |
| 30 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.00670590 |
| 31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.00603910 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.00014277 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.99398119 |
| 34 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.99259463 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.97170990 |
| 36 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.96949696 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.95719806 |
| 38 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.93419880 |
| 39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.90022138 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.86730406 |
| 41 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.83731484 |
| 42 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.83009025 |
| 43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.82712117 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.82219735 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.79874515 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.78466154 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.78300504 |
| 48 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.75491342 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72198310 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.71340385 |
| 51 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.69602538 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.67562791 |
| 53 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.67556758 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.66581663 |
| 55 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.61972901 |
| 56 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.61263281 |
| 57 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61154489 |
| 58 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.60334370 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58603298 |
| 60 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58426965 |
| 61 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.58031370 |
| 62 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.57449850 |
| 63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.56953116 |
| 64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56843910 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56025194 |
| 66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.55075306 |
| 67 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.50928367 |
| 68 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50233536 |
| 69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.48986426 |
| 70 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.47117005 |
| 71 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.46735610 |
| 72 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.46460462 |
| 73 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.45244070 |
| 74 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45067994 |
| 75 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.42863335 |
| 76 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.41383712 |
| 77 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.41380088 |
| 78 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.41221006 |
| 79 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.40188420 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40142939 |
| 81 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39424093 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.39122733 |
| 83 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.38822357 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38552256 |
| 85 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34441317 |
| 86 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33490068 |
| 87 | P68_20966046_ChIP-Seq_HELA_Human | 1.32452978 |
| 88 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.30944407 |
| 89 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.30916971 |
| 90 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.30326561 |
| 91 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.29948852 |
| 92 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29870958 |
| 93 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.27799877 |
| 94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.27694042 |
| 95 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26339835 |
| 96 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.25728842 |
| 97 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.25251010 |
| 98 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.21630494 |
| 99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19947683 |
| 100 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18873102 |
| 101 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.18710989 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18542187 |
| 103 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.18308352 |
| 104 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17941673 |
| 105 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17292670 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17292670 |
| 107 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16746058 |
| 108 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.15338535 |
| 109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.14521462 |
| 110 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.14117348 |
| 111 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13618123 |
| 112 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.13112458 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.12441657 |
| 114 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.12242825 |
| 115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12063651 |
| 116 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.12010607 |
| 117 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11708174 |
| 118 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11263237 |
| 119 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.11247279 |
| 120 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11232202 |
| 121 | FUS_26573619_Chip-Seq_HEK293_Human | 1.11075629 |
| 122 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10591674 |
| 123 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.09913461 |
| 124 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.09720077 |
| 125 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09628943 |
| 126 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08870193 |
| 127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08592237 |
| 128 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07536079 |
| 129 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07284901 |
| 130 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07084607 |
| 131 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.06912496 |
| 132 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.05740810 |
| 133 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05239696 |
| 134 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02965626 |
| 135 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02447845 |
| 136 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02169571 |
| 137 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.01959946 |
| 138 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01243495 |
| 139 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.01123543 |
| 140 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00329227 |
| 141 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00220902 |
| 142 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98726190 |
| 143 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98219190 |
| 144 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98070018 |
| 145 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97934717 |
| 146 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97615548 |
| 147 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.97481012 |
| 148 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.97460005 |
| 149 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97402753 |
| 150 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.96852403 |
| 151 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.96817872 |
| 152 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96733206 |
| 153 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96526254 |
| 154 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95855794 |
| 155 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95825269 |
| 156 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95329931 |
| 157 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95256445 |
| 158 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.95062770 |
| 159 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94537079 |
| 160 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.92964093 |
| 161 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92644879 |
| 162 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92186912 |
| 163 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92060722 |
| 164 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91875259 |
| 165 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91846694 |
| 166 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91671864 |
| 167 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.91378649 |
| 168 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.91285078 |
| 169 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90666370 |
| 170 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.90530129 |
| 171 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90328201 |
| 172 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90328201 |
| 173 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90255592 |
| 174 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.89257356 |
| 175 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89058822 |
| 176 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.88542952 |
| 177 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.88521158 |
| 178 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88458470 |
| 179 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87961471 |
| 180 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.87807317 |
| 181 | TBL1_22424771_ChIP-Seq_293T_Human | 0.87118843 |
| 182 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.86905210 |
| 183 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86430932 |
| 184 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86386610 |
| 185 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.86189033 |
| 186 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85996598 |
| 187 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.85977926 |
| 188 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85651265 |
| 189 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85358531 |
| 190 | ATF3_27146783_Chip-Seq_COLON_Human | 0.83505886 |
| 191 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.83458301 |
| 192 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.83131704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.19321121 |
| 2 | MP0005360_urolithiasis | 5.76208402 |
| 3 | MP0000920_abnormal_myelination | 5.21335842 |
| 4 | MP0005365_abnormal_bile_salt | 4.13344648 |
| 5 | MP0003880_abnormal_central_pattern | 4.11813293 |
| 6 | MP0003122_maternal_imprinting | 3.98542829 |
| 7 | MP0003950_abnormal_plasma_membrane | 3.96277512 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.65073371 |
| 9 | MP0004270_analgesia | 3.39914889 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.27533290 |
| 11 | MP0001529_abnormal_vocalization | 2.95290418 |
| 12 | MP0003690_abnormal_glial_cell | 2.91465126 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.88668256 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.86560265 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.81548324 |
| 16 | MP0005171_absent_coat_pigmentation | 2.72207906 |
| 17 | MP0003123_paternal_imprinting | 2.71488251 |
| 18 | MP0003329_amyloid_beta_deposits | 2.71049939 |
| 19 | MP0002272_abnormal_nervous_system | 2.64454629 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 2.61978655 |
| 21 | MP0001905_abnormal_dopamine_level | 2.61434903 |
| 22 | MP0005670_abnormal_white_adipose | 2.54724054 |
| 23 | MP0004742_abnormal_vestibular_system | 2.53882230 |
| 24 | MP0001486_abnormal_startle_reflex | 2.46095331 |
| 25 | MP0004885_abnormal_endolymph | 2.39007572 |
| 26 | MP0002064_seizures | 2.37475499 |
| 27 | MP0004859_abnormal_synaptic_plasticity | 2.37367077 |
| 28 | MP0004142_abnormal_muscle_tone | 2.35984722 |
| 29 | MP0003634_abnormal_glial_cell | 2.27512502 |
| 30 | MP0003136_yellow_coat_color | 2.27302010 |
| 31 | MP0003868_abnormal_feces_composition | 2.22684744 |
| 32 | MP0001485_abnormal_pinna_reflex | 2.04967503 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 2.02562331 |
| 34 | MP0000778_abnormal_nervous_system | 1.98058527 |
| 35 | MP0004043_abnormal_pH_regulation | 1.96885905 |
| 36 | MP0003879_abnormal_hair_cell | 1.96466985 |
| 37 | MP0009046_muscle_twitch | 1.95979864 |
| 38 | MP0002089_abnormal_postnatal_growth/wei | 1.91050880 |
| 39 | MP0003635_abnormal_synaptic_transmissio | 1.89089786 |
| 40 | MP0009745_abnormal_behavioral_response | 1.88832945 |
| 41 | MP0002229_neurodegeneration | 1.86185289 |
| 42 | MP0005410_abnormal_fertilization | 1.80065966 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.79793492 |
| 44 | MP0003632_abnormal_nervous_system | 1.73947189 |
| 45 | MP0010234_abnormal_vibrissa_follicle | 1.73784382 |
| 46 | MP0005409_darkened_coat_color | 1.71816527 |
| 47 | MP0005423_abnormal_somatic_nervous | 1.70232900 |
| 48 | MP0004264_abnormal_extraembryonic_tissu | 1.66195220 |
| 49 | MP0005451_abnormal_body_composition | 1.64453524 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.63195146 |
| 51 | MP0003252_abnormal_bile_duct | 1.61131541 |
| 52 | MP0001970_abnormal_pain_threshold | 1.59616440 |
| 53 | MP0002572_abnormal_emotion/affect_behav | 1.57077116 |
| 54 | MP0005332_abnormal_amino_acid | 1.51950640 |
| 55 | MP0008260_abnormal_autophagy | 1.51143670 |
| 56 | MP0002735_abnormal_chemical_nociception | 1.50363712 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.49862627 |
| 58 | MP0004381_abnormal_hair_follicle | 1.49648650 |
| 59 | MP0000604_amyloidosis | 1.49569627 |
| 60 | MP0001440_abnormal_grooming_behavior | 1.47664730 |
| 61 | MP0003631_nervous_system_phenotype | 1.47436421 |
| 62 | MP0008569_lethality_at_weaning | 1.45469938 |
| 63 | MP0000609_abnormal_liver_physiology | 1.42490740 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 1.42339533 |
| 65 | MP0002063_abnormal_learning/memory/cond | 1.40197936 |
| 66 | MP0000955_abnormal_spinal_cord | 1.40042788 |
| 67 | MP0001968_abnormal_touch/_nociception | 1.36688292 |
| 68 | MP0002067_abnormal_sensory_capabilities | 1.35788436 |
| 69 | MP0002882_abnormal_neuron_morphology | 1.35202399 |
| 70 | MP0000462_abnormal_digestive_system | 1.34680838 |
| 71 | MP0003633_abnormal_nervous_system | 1.33907934 |
| 72 | MP0001756_abnormal_urination | 1.31394803 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 1.30699377 |
| 74 | MP0003806_abnormal_nucleotide_metabolis | 1.30248717 |
| 75 | MP0001963_abnormal_hearing_physiology | 1.30244988 |
| 76 | MP0001765_abnormal_ion_homeostasis | 1.29904039 |
| 77 | MP0005257_abnormal_intraocular_pressure | 1.28728805 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 1.28348227 |
| 79 | MP0002066_abnormal_motor_capabilities/c | 1.28298364 |
| 80 | MP0006054_spinal_hemorrhage | 1.27698810 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.27506679 |
| 82 | MP0002733_abnormal_thermal_nociception | 1.26725950 |
| 83 | MP0010678_abnormal_skin_adnexa | 1.24753536 |
| 84 | MP0001346_abnormal_lacrimal_gland | 1.23889957 |
| 85 | MP0005386_behavior/neurological_phenoty | 1.23501283 |
| 86 | MP0004924_abnormal_behavior | 1.23501283 |
| 87 | MP0004272_abnormal_basement_membrane | 1.23072507 |
| 88 | MP0004019_abnormal_vitamin_homeostasis | 1.21838379 |
| 89 | MP0002736_abnormal_nociception_after | 1.21581938 |
| 90 | MP0000003_abnormal_adipose_tissue | 1.19626743 |
| 91 | MP0000383_abnormal_hair_follicle | 1.18624115 |
| 92 | MP0002971_abnormal_brown_adipose | 1.18243092 |
| 93 | MP0002752_abnormal_somatic_nervous | 1.17758688 |
| 94 | MP0009384_cardiac_valve_regurgitation | 1.15598524 |
| 95 | MP0009643_abnormal_urine_homeostasis | 1.15483929 |
| 96 | MP0005408_hypopigmentation | 1.15467454 |
| 97 | MP0000747_muscle_weakness | 1.13274275 |
| 98 | MP0004147_increased_porphyrin_level | 1.13232701 |
| 99 | MP0004134_abnormal_chest_morphology | 1.12979211 |
| 100 | MP0005666_abnormal_adipose_tissue | 1.11472885 |
| 101 | MP0003195_calcinosis | 1.07081049 |
| 102 | MP0002909_abnormal_adrenal_gland | 1.05796148 |
| 103 | MP0005058_abnormal_lysosome_morphology | 1.02955769 |
| 104 | MP0000678_abnormal_parathyroid_gland | 1.02593666 |
| 105 | MP0000639_abnormal_adrenal_gland | 1.01682136 |
| 106 | MP0005375_adipose_tissue_phenotype | 1.00904006 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.96454257 |
| 108 | MP0005195_abnormal_posterior_eye | 0.95900041 |
| 109 | MP0000013_abnormal_adipose_tissue | 0.93453962 |
| 110 | MP0005645_abnormal_hypothalamus_physiol | 0.92277318 |
| 111 | MP0010368_abnormal_lymphatic_system | 0.90425175 |
| 112 | MP0001501_abnormal_sleep_pattern | 0.90413077 |
| 113 | MP0003866_abnormal_defecation | 0.90411354 |
| 114 | MP0003566_abnormal_cell_adhesion | 0.88419095 |
| 115 | MP0006082_CNS_inflammation | 0.88410666 |
| 116 | MP0002078_abnormal_glucose_homeostasis | 0.86979034 |
| 117 | MP0009115_abnormal_fat_cell | 0.86694612 |
| 118 | MP0001851_eye_inflammation | 0.86549951 |
| 119 | MP0001915_intracranial_hemorrhage | 0.86391946 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.86117081 |
| 121 | MP0000026_abnormal_inner_ear | 0.86108600 |
| 122 | MP0002184_abnormal_innervation | 0.85745681 |
| 123 | MP0009840_abnormal_foam_cell | 0.85411347 |
| 124 | MP0003938_abnormal_ear_development | 0.84887865 |
| 125 | MP0005623_abnormal_meninges_morphology | 0.84402303 |
| 126 | MP0000762_abnormal_tongue_morphology | 0.83634438 |
| 127 | MP0006276_abnormal_autonomic_nervous | 0.82541480 |
| 128 | MP0004145_abnormal_muscle_electrophysio | 0.82237668 |
| 129 | MP0009642_abnormal_blood_homeostasis | 0.80985864 |
| 130 | MP0002295_abnormal_pulmonary_circulatio | 0.80637366 |
| 131 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79422974 |
| 132 | MP0001348_abnormal_lacrimal_gland | 0.79138845 |
| 133 | MP0005448_abnormal_energy_balance | 0.78867700 |
| 134 | MP0001661_extended_life_span | 0.77715378 |
| 135 | MP0000579_abnormal_nail_morphology | 0.77317203 |
| 136 | MP0002132_abnormal_respiratory_system | 0.77161733 |
| 137 | MP0000566_synostosis | 0.76932640 |
| 138 | MP0003953_abnormal_hormone_level | 0.76344501 |
| 139 | MP0001502_abnormal_circadian_rhythm | 0.75878711 |
| 140 | MP0002152_abnormal_brain_morphology | 0.74800141 |
| 141 | MP0002557_abnormal_social/conspecific_i | 0.73947443 |
| 142 | MP0000751_myopathy | 0.73246577 |
| 143 | MP0005253_abnormal_eye_physiology | 0.73208541 |
| 144 | MP0001270_distended_abdomen | 0.72970954 |
| 145 | MP0002896_abnormal_bone_mineralization | 0.72752433 |
| 146 | MP0003705_abnormal_hypodermis_morpholog | 0.72608688 |
| 147 | MP0003121_genomic_imprinting | 0.71659460 |
| 148 | MP0002090_abnormal_vision | 0.71346714 |
| 149 | MP0001177_atelectasis | 0.71205599 |
| 150 | MP0005319_abnormal_enzyme/_coenzyme | 0.71150696 |
| 151 | MP0000598_abnormal_liver_morphology | 0.70373337 |
| 152 | MP0005076_abnormal_cell_differentiation | 0.69540338 |
| 153 | MP0001986_abnormal_taste_sensitivity | 0.66210748 |
| 154 | MP0000749_muscle_degeneration | 0.65698469 |
| 155 | MP0000647_abnormal_sebaceous_gland | 0.65419757 |
| 156 | MP0004185_abnormal_adipocyte_glucose | 0.64519808 |
| 157 | MP0005646_abnormal_pituitary_gland | 0.64270777 |
| 158 | MP0002822_catalepsy | 0.63457218 |
| 159 | MP0001727_abnormal_embryo_implantation | 0.62875976 |
| 160 | MP0002933_joint_inflammation | 0.62141815 |
| 161 | MP0004036_abnormal_muscle_relaxation | 0.61686843 |
| 162 | MP0003075_altered_response_to | 0.61656079 |
| 163 | MP0004811_abnormal_neuron_physiology | 0.61083541 |
| 164 | MP0002970_abnormal_white_adipose | 0.61020301 |
| 165 | MP0000477_abnormal_intestine_morphology | 0.60365893 |
| 166 | MP0006072_abnormal_retinal_apoptosis | 0.57565754 |
| 167 | MP0001664_abnormal_digestion | 0.56992595 |
| 168 | MP0005388_respiratory_system_phenotype | 0.54875547 |
| 169 | MP0002133_abnormal_respiratory_system | 0.54875547 |
| 170 | MP0001764_abnormal_homeostasis | 0.54095618 |
| 171 | MP0005330_cardiomyopathy | 0.52473627 |
| 172 | MP0005023_abnormal_wound_healing | 0.52407768 |
| 173 | MP0003115_abnormal_respiratory_system | 0.50867917 |
| 174 | MP0002136_abnormal_kidney_physiology | 0.50202711 |
| 175 | MP0005464_abnormal_platelet_physiology | 0.47119676 |
| 176 | MP0000534_abnormal_ureter_morphology | 0.44514714 |
| 177 | MP0005084_abnormal_gallbladder_morpholo | 0.44205682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 8.60821597 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.38288828 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.38288828 |
| 4 | Neurofibrillary tangles (HP:0002185) | 5.98252019 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.44400536 |
| 6 | Joint hemorrhage (HP:0005261) | 5.20656565 |
| 7 | Hemorrhage of the eye (HP:0011885) | 4.96985424 |
| 8 | Abnormality of the corticospinal tract (HP:0002492) | 4.72347734 |
| 9 | Complement deficiency (HP:0004431) | 4.65155006 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.44363639 |
| 11 | Parakeratosis (HP:0001036) | 4.41528108 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 4.36975726 |
| 13 | Peripheral hypomyelination (HP:0007182) | 4.31271291 |
| 14 | Xanthomatosis (HP:0000991) | 4.26839666 |
| 15 | Sensory axonal neuropathy (HP:0003390) | 4.20924665 |
| 16 | Onion bulb formation (HP:0003383) | 4.03137135 |
| 17 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.02953461 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.93503073 |
| 19 | Cerebral hypomyelination (HP:0006808) | 3.90145437 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 3.87020358 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 3.82813999 |
| 22 | Flat acetabular roof (HP:0003180) | 3.80777235 |
| 23 | Abnormality of complement system (HP:0005339) | 3.73812033 |
| 24 | Abnormality of carpal bone ossification (HP:0006257) | 3.69408892 |
| 25 | Hypercholesterolemia (HP:0003124) | 3.66658284 |
| 26 | Glomerulonephritis (HP:0000099) | 3.64845365 |
| 27 | Abnormal auditory evoked potentials (HP:0006958) | 3.64299024 |
| 28 | Insidious onset (HP:0003587) | 3.40183264 |
| 29 | Termporal pattern (HP:0011008) | 3.40183264 |
| 30 | Myokymia (HP:0002411) | 3.32654062 |
| 31 | Hypolipoproteinemia (HP:0010981) | 3.29858626 |
| 32 | Spastic gait (HP:0002064) | 3.27482087 |
| 33 | Abnormal tarsal ossification (HP:0008369) | 3.10007903 |
| 34 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.09980926 |
| 35 | Menorrhagia (HP:0000132) | 3.06395734 |
| 36 | Spontaneous abortion (HP:0005268) | 3.03715771 |
| 37 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.03690685 |
| 38 | Leukodystrophy (HP:0002415) | 3.03606083 |
| 39 | Vascular calcification (HP:0004934) | 3.02082126 |
| 40 | Intention tremor (HP:0002080) | 2.97162788 |
| 41 | Abnormality of glycolysis (HP:0004366) | 2.96360967 |
| 42 | Increased serum pyruvate (HP:0003542) | 2.96360967 |
| 43 | Alacrima (HP:0000522) | 2.96264350 |
| 44 | Dysmetria (HP:0001310) | 2.95307350 |
| 45 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.86538974 |
| 46 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.86321810 |
| 47 | Scanning speech (HP:0002168) | 2.84734480 |
| 48 | Abnormal ossification of hand bones (HP:0005921) | 2.77048703 |
| 49 | Cardiovascular calcification (HP:0011915) | 2.73382592 |
| 50 | Abnormal hand bone ossification (HP:0010660) | 2.73161217 |
| 51 | Acanthocytosis (HP:0001927) | 2.73008489 |
| 52 | Hypoplastic pelvis (HP:0008839) | 2.71227099 |
| 53 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.70447845 |
| 54 | Mucopolysacchariduria (HP:0008155) | 2.70447845 |
| 55 | Retinal dysplasia (HP:0007973) | 2.68491659 |
| 56 | Small epiphyses (HP:0010585) | 2.67642456 |
| 57 | Protrusio acetabuli (HP:0003179) | 2.67146697 |
| 58 | Epidermoid cyst (HP:0200040) | 2.67084817 |
| 59 | Neonatal short-limb short stature (HP:0008921) | 2.66421916 |
| 60 | Absent septum pellucidum (HP:0001331) | 2.66229451 |
| 61 | Slow saccadic eye movements (HP:0000514) | 2.63777167 |
| 62 | Cerebral hemorrhage (HP:0001342) | 2.61681383 |
| 63 | Purpura (HP:0000979) | 2.61416927 |
| 64 | CNS hypomyelination (HP:0003429) | 2.58222312 |
| 65 | Axonal loss (HP:0003447) | 2.56261047 |
| 66 | Hydroxyprolinuria (HP:0003080) | 2.53593550 |
| 67 | Abnormality of proline metabolism (HP:0010907) | 2.53593550 |
| 68 | Hypoalphalipoproteinemia (HP:0003233) | 2.52080629 |
| 69 | Skin nodule (HP:0200036) | 2.51727461 |
| 70 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51502554 |
| 71 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51502554 |
| 72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51502554 |
| 73 | Autoamputation (HP:0001218) | 2.51075183 |
| 74 | Asymmetry of the thorax (HP:0001555) | 2.50279968 |
| 75 | Intrahepatic cholestasis (HP:0001406) | 2.48894870 |
| 76 | Thickened helices (HP:0000391) | 2.47189416 |
| 77 | Ankle clonus (HP:0011448) | 2.46658990 |
| 78 | Akinesia (HP:0002304) | 2.42487892 |
| 79 | Fat malabsorption (HP:0002630) | 2.42124771 |
| 80 | Pheochromocytoma (HP:0002666) | 2.41836272 |
| 81 | Conjugated hyperbilirubinemia (HP:0002908) | 2.41387268 |
| 82 | Broad alveolar ridges (HP:0000187) | 2.39557466 |
| 83 | Increased circulating renin level (HP:0000848) | 2.36150340 |
| 84 | Decreased lacrimation (HP:0000633) | 2.35557457 |
| 85 | Gingival bleeding (HP:0000225) | 2.34454137 |
| 86 | Clumsiness (HP:0002312) | 2.34180147 |
| 87 | Focal motor seizures (HP:0011153) | 2.33540751 |
| 88 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.33154802 |
| 89 | Flared iliac wings (HP:0002869) | 2.30961279 |
| 90 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.30677276 |
| 91 | Broad palm (HP:0001169) | 2.30401728 |
| 92 | Premature skin wrinkling (HP:0100678) | 2.28503340 |
| 93 | Dysostosis multiplex (HP:0000943) | 2.28326930 |
| 94 | Muscle fiber splitting (HP:0003555) | 2.25896249 |
| 95 | Spastic paraparesis (HP:0002313) | 2.24458837 |
| 96 | Abnormality of the septum pellucidum (HP:0007375) | 2.24300106 |
| 97 | Morphological abnormality of the inner ear (HP:0011390) | 2.22648700 |
| 98 | Mitral stenosis (HP:0001718) | 2.21183129 |
| 99 | Poor speech (HP:0002465) | 2.21031017 |
| 100 | Hypoglycemic coma (HP:0001325) | 2.20621497 |
| 101 | Split foot (HP:0001839) | 2.20376125 |
| 102 | Abnormality of the lumbar spine (HP:0100712) | 2.20031449 |
| 103 | Pigmentary retinal degeneration (HP:0001146) | 2.19532110 |
| 104 | Epiphyseal dysplasia (HP:0002656) | 2.18691047 |
| 105 | Metabolic alkalosis (HP:0200114) | 2.18329875 |
| 106 | Foot dorsiflexor weakness (HP:0009027) | 2.17463629 |
| 107 | Stridor (HP:0010307) | 2.17233400 |
| 108 | Anteriorly placed anus (HP:0001545) | 2.15969958 |
| 109 | Abnormality of the acetabulum (HP:0003170) | 2.14601165 |
| 110 | Limb dystonia (HP:0002451) | 2.13963840 |
| 111 | Spastic tetraparesis (HP:0001285) | 2.13125305 |
| 112 | Vaginal fistula (HP:0004320) | 2.12881761 |
| 113 | Decreased motor nerve conduction velocity (HP:0003431) | 2.11789444 |
| 114 | Neuroendocrine neoplasm (HP:0100634) | 2.11585289 |
| 115 | Renal Fanconi syndrome (HP:0001994) | 2.10644069 |
| 116 | Epileptic encephalopathy (HP:0200134) | 2.10538571 |
| 117 | Nephritis (HP:0000123) | 2.09206288 |
| 118 | Neonatal death (HP:0003811) | 2.09180037 |
| 119 | Bronchomalacia (HP:0002780) | 2.07537088 |
| 120 | Hypophosphatemic rickets (HP:0004912) | 2.06605606 |
| 121 | Lower limb muscle weakness (HP:0007340) | 2.05365761 |
| 122 | Aplasia involving bones of the extremities (HP:0009825) | 2.04663896 |
| 123 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.04663896 |
| 124 | Aplasia of the phalanges of the hand (HP:0009802) | 2.04663896 |
| 125 | Vaginal atresia (HP:0000148) | 2.03910532 |
| 126 | Methylmalonic acidemia (HP:0002912) | 2.03844903 |
| 127 | Hypomagnesemia (HP:0002917) | 2.02628944 |
| 128 | Infantile muscular hypotonia (HP:0008947) | 2.02606064 |
| 129 | 3-Methylglutaconic aciduria (HP:0003535) | 1.99496457 |
| 130 | Patchy hypopigmentation of hair (HP:0011365) | 1.98479391 |
| 131 | Hyperactive renin-angiotensin system (HP:0000841) | 1.98070992 |
| 132 | Amyloidosis (HP:0011034) | 1.97886647 |
| 133 | Hepatosplenomegaly (HP:0001433) | 1.97237308 |
| 134 | White forelock (HP:0002211) | 1.96652278 |
| 135 | Irregular epiphyses (HP:0010582) | 1.96474254 |
| 136 | Ileus (HP:0002595) | 1.95290418 |
| 137 | Cerebral aneurysm (HP:0004944) | 1.94814807 |
| 138 | Abnormality of the foot musculature (HP:0001436) | 1.93761786 |
| 139 | Potter facies (HP:0002009) | 1.93421296 |
| 140 | Facial shape deformation (HP:0011334) | 1.93421296 |
| 141 | Action tremor (HP:0002345) | 1.93401720 |
| 142 | Genital tract atresia (HP:0001827) | 1.92411247 |
| 143 | Choreoathetosis (HP:0001266) | 1.92170296 |
| 144 | Cupped ribs (HP:0000887) | 1.91506490 |
| 145 | Prolonged neonatal jaundice (HP:0006579) | 1.90921578 |
| 146 | Widely patent fontanelles and sutures (HP:0004492) | 1.89490414 |
| 147 | Coxa vara (HP:0002812) | 1.88630704 |
| 148 | Hyperlipoproteinemia (HP:0010980) | 1.88591725 |
| 149 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.87835470 |
| 150 | Acute necrotizing encephalopathy (HP:0006965) | 1.87011643 |
| 151 | Megalencephaly (HP:0001355) | 1.86845459 |
| 152 | Septo-optic dysplasia (HP:0100842) | 1.86533983 |
| 153 | Late onset (HP:0003584) | 1.85609775 |
| 154 | Distal sensory impairment (HP:0002936) | 1.83796420 |
| 155 | Hypotension (HP:0002615) | 1.83592896 |
| 156 | Hypokalemic alkalosis (HP:0001949) | 1.83450915 |
| 157 | Hypoplasia of the iris (HP:0007676) | 1.83008494 |
| 158 | Progressive neurologic deterioration (HP:0002344) | 1.81950626 |
| 159 | Ovoid vertebral bodies (HP:0003300) | 1.81487681 |
| 160 | Peripheral demyelination (HP:0011096) | 1.80699011 |
| 161 | Paraparesis (HP:0002385) | 1.79153697 |
| 162 | Myocardial infarction (HP:0001658) | 1.77823177 |
| 163 | Vertebral compression fractures (HP:0002953) | 1.76302444 |
| 164 | Abnormality of the Achilles tendon (HP:0005109) | 1.75877389 |
| 165 | Hyporeflexia of lower limbs (HP:0002600) | 1.75461534 |
| 166 | Atonic seizures (HP:0010819) | 1.74694226 |
| 167 | Right ventricular cardiomyopathy (HP:0011663) | 1.74158366 |
| 168 | Abnormal delivery (HP:0001787) | 1.73947213 |
| 169 | Hammertoe (HP:0001765) | 1.72611547 |
| 170 | Humeroradial synostosis (HP:0003041) | 1.72313492 |
| 171 | Synostosis involving the elbow (HP:0003938) | 1.72313492 |
| 172 | Gowers sign (HP:0003391) | 1.71667661 |
| 173 | Postnatal microcephaly (HP:0005484) | 1.71431526 |
| 174 | Abnormal foot bone ossification (HP:0010675) | 1.70879308 |
| 175 | Generalized myoclonic seizures (HP:0002123) | 1.70441878 |
| 176 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.69941056 |
| 177 | Rickets (HP:0002748) | 1.69648395 |
| 178 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.69468043 |
| 179 | Abnormality of the intrinsic pathway (HP:0010989) | 1.69138005 |
| 180 | Limited elbow extension (HP:0001377) | 1.68538112 |
| 181 | Abnormality of the wing of the ilium (HP:0011867) | 1.68033361 |
| 182 | Neuronal loss in central nervous system (HP:0002529) | 1.67940822 |
| 183 | Impaired pain sensation (HP:0007328) | 1.67843651 |
| 184 | Abnormality of pain sensation (HP:0010832) | 1.67843651 |
| 185 | Erythroderma (HP:0001019) | 1.67237091 |
| 186 | Glomerulosclerosis (HP:0000096) | 1.64024120 |
| 187 | Neonatal onset (HP:0003623) | 1.63007596 |
| 188 | Enlarged kidneys (HP:0000105) | 1.62449109 |
| 189 | Abnormality of renin-angiotensin system (HP:0000847) | 1.60797113 |
| 190 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.60341376 |
| 191 | Thrombophlebitis (HP:0004418) | 1.60071258 |
| 192 | Hypertriglyceridemia (HP:0002155) | 1.58339475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.83450681 |
| 2 | FGFR4 | 5.05964714 |
| 3 | OXSR1 | 4.27451824 |
| 4 | RIPK1 | 3.90407521 |
| 5 | EPHA2 | 3.54383070 |
| 6 | FGFR3 | 3.39504077 |
| 7 | ERN1 | 2.92450309 |
| 8 | EPHB1 | 2.88897525 |
| 9 | PRPF4B | 2.88839047 |
| 10 | MAPKAPK5 | 2.84126949 |
| 11 | PKN1 | 2.79132979 |
| 12 | BCR | 2.73524478 |
| 13 | MST1R | 2.52425970 |
| 14 | TRIB3 | 2.48241641 |
| 15 | PBK | 2.38281695 |
| 16 | CDK19 | 2.34327157 |
| 17 | WNK4 | 2.23496901 |
| 18 | MET | 2.19183304 |
| 19 | DDR2 | 2.15815827 |
| 20 | CASK | 2.15161773 |
| 21 | LMTK2 | 2.12195850 |
| 22 | FGFR2 | 2.03579241 |
| 23 | MST4 | 1.98076485 |
| 24 | LIMK1 | 1.93487454 |
| 25 | CSNK1G3 | 1.91959392 |
| 26 | PDGFRA | 1.88678521 |
| 27 | PKN2 | 1.84411758 |
| 28 | CSNK1A1L | 1.79942670 |
| 29 | UHMK1 | 1.79209181 |
| 30 | WNK1 | 1.77497781 |
| 31 | PNCK | 1.76048736 |
| 32 | CAMK2B | 1.75932113 |
| 33 | SIK1 | 1.70380965 |
| 34 | SIK2 | 1.68277116 |
| 35 | NTRK1 | 1.65618437 |
| 36 | NEK6 | 1.62870838 |
| 37 | TESK2 | 1.59403102 |
| 38 | TNIK | 1.59269352 |
| 39 | EEF2K | 1.52671467 |
| 40 | CDK12 | 1.51443505 |
| 41 | CSNK1G1 | 1.45999782 |
| 42 | ROCK2 | 1.45754709 |
| 43 | CSNK1G2 | 1.44089486 |
| 44 | CAMK2D | 1.39055385 |
| 45 | EPHA4 | 1.39026189 |
| 46 | DYRK1B | 1.36354913 |
| 47 | FGR | 1.31409354 |
| 48 | SGK494 | 1.25132218 |
| 49 | SGK223 | 1.25132218 |
| 50 | PRKAA2 | 1.23975256 |
| 51 | MAPKAPK3 | 1.23860791 |
| 52 | MUSK | 1.19289915 |
| 53 | CLK1 | 1.17152516 |
| 54 | CAMK2G | 1.15967679 |
| 55 | RET | 1.15546345 |
| 56 | FGFR1 | 1.13516332 |
| 57 | CDC42BPA | 1.10024889 |
| 58 | EPHA3 | 1.09812281 |
| 59 | MAPK11 | 1.09330799 |
| 60 | MAP2K6 | 1.09033060 |
| 61 | PAK6 | 1.07464102 |
| 62 | MARK1 | 1.07178576 |
| 63 | DYRK2 | 1.00497633 |
| 64 | CAMK2A | 1.00419862 |
| 65 | PTK2 | 0.99233674 |
| 66 | TYRO3 | 0.97950905 |
| 67 | MAP3K2 | 0.93474249 |
| 68 | MAP3K1 | 0.86606748 |
| 69 | IRAK3 | 0.86493327 |
| 70 | BMPR1B | 0.83491011 |
| 71 | CDK14 | 0.83305062 |
| 72 | PHKG2 | 0.82569652 |
| 73 | PHKG1 | 0.82569652 |
| 74 | ICK | 0.81566218 |
| 75 | CDK5 | 0.80954038 |
| 76 | PTK6 | 0.77105971 |
| 77 | TRPM7 | 0.76485993 |
| 78 | PRKCE | 0.76359798 |
| 79 | ERBB2 | 0.75017736 |
| 80 | CDK15 | 0.74581878 |
| 81 | PRKAA1 | 0.74387062 |
| 82 | MAP3K7 | 0.72890179 |
| 83 | MARK2 | 0.72441474 |
| 84 | LATS2 | 0.72399723 |
| 85 | PRKG2 | 0.72243420 |
| 86 | PRKCQ | 0.72214308 |
| 87 | MAPK15 | 0.71450645 |
| 88 | CDK18 | 0.70687807 |
| 89 | MAP2K3 | 0.69674359 |
| 90 | TESK1 | 0.67436098 |
| 91 | AKT3 | 0.67160739 |
| 92 | CDK11A | 0.65241553 |
| 93 | PRKD1 | 0.65197320 |
| 94 | NEK9 | 0.63297907 |
| 95 | TAOK2 | 0.62107731 |
| 96 | MAP3K11 | 0.60695746 |
| 97 | PAK3 | 0.60253848 |
| 98 | PDPK1 | 0.60062193 |
| 99 | ARAF | 0.60027506 |
| 100 | NTRK3 | 0.59730772 |
| 101 | RPS6KA5 | 0.57774710 |
| 102 | MAP3K9 | 0.57611570 |
| 103 | MATK | 0.57449944 |
| 104 | FLT3 | 0.56459958 |
| 105 | ERBB4 | 0.56153446 |
| 106 | FER | 0.55805724 |
| 107 | NTRK2 | 0.55600241 |
| 108 | MAP3K3 | 0.53700392 |
| 109 | TGFBR2 | 0.52448766 |
| 110 | SGK1 | 0.52248078 |
| 111 | GRK7 | 0.52082018 |
| 112 | TAOK1 | 0.51827573 |
| 113 | PRKCH | 0.51760858 |
| 114 | PRKG1 | 0.50983118 |
| 115 | MAP3K13 | 0.49828182 |
| 116 | PRKACB | 0.49430297 |
| 117 | MAPK13 | 0.49340875 |
| 118 | SRC | 0.48432982 |
| 119 | SGK3 | 0.48032733 |
| 120 | PRKD2 | 0.47785186 |
| 121 | TYK2 | 0.47476182 |
| 122 | CSNK1D | 0.47356942 |
| 123 | FYN | 0.46763323 |
| 124 | SMG1 | 0.46439930 |
| 125 | NME1 | 0.45266167 |
| 126 | GRK5 | 0.44867174 |
| 127 | CSNK1A1 | 0.44853325 |
| 128 | STK38 | 0.44588003 |
| 129 | ADRBK2 | 0.43711067 |
| 130 | FES | 0.43160593 |
| 131 | MTOR | 0.42042748 |
| 132 | RPS6KB1 | 0.41834232 |
| 133 | DAPK3 | 0.41833389 |
| 134 | GRK1 | 0.41058185 |
| 135 | BMPR2 | 0.40361978 |
| 136 | STK11 | 0.40338613 |
| 137 | MAP2K2 | 0.38909286 |
| 138 | GSK3A | 0.38739397 |
| 139 | ITK | 0.38584805 |
| 140 | PRKACG | 0.38545455 |
| 141 | STK16 | 0.38388915 |
| 142 | PRKACA | 0.36139602 |
| 143 | PTK2B | 0.34965579 |
| 144 | PLK2 | 0.34882071 |
| 145 | MAP2K1 | 0.33978553 |
| 146 | MAPK7 | 0.33647775 |
| 147 | KSR2 | 0.32230978 |
| 148 | MAP2K7 | 0.32185033 |
| 149 | IRAK2 | 0.31832062 |
| 150 | DMPK | 0.30169496 |
| 151 | PAK1 | 0.29447042 |
| 152 | CSNK1E | 0.29362933 |
| 153 | RPS6KA2 | 0.29337443 |
| 154 | PRKCZ | 0.28565182 |
| 155 | MINK1 | 0.28479926 |
| 156 | INSR | 0.27068864 |
| 157 | PDK1 | 0.25453092 |
| 158 | MAP3K5 | 0.25355701 |
| 159 | OBSCN | 0.25352705 |
| 160 | PIK3CA | 0.25080848 |
| 161 | MAPK3 | 0.24900703 |
| 162 | BLK | 0.24842628 |
| 163 | LATS1 | 0.24476280 |
| 164 | DYRK1A | 0.24098506 |
| 165 | PRKCG | 0.23646204 |
| 166 | DAPK2 | 0.23094755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.69934413 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.53551357 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.23411180 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.76706604 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.98907006 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.97502731 |
| 7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.97321773 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.95806366 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.75053981 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61268092 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.60188864 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.59211067 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.53042112 |
| 14 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.37254782 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.29284070 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.27595064 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.26916768 |
| 18 | * Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.13300111 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.01382014 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00892021 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.88121335 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.88012935 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.86604123 |
| 24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.86015469 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.85655913 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.85311842 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.81732519 |
| 28 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.79024134 |
| 29 | Protein export_Homo sapiens_hsa03060 | 1.78498391 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.72638774 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.65853540 |
| 32 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.64800785 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55787921 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.53765106 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53749658 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.53293348 |
| 37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.48599319 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.48191828 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44498198 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42003258 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.41728016 |
| 42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.41355143 |
| 43 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.41129228 |
| 44 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.34629484 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.32291775 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.23569576 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22579148 |
| 48 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.20752684 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20571978 |
| 50 | Galactose metabolism_Homo sapiens_hsa00052 | 1.18391979 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18188539 |
| 52 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.17751759 |
| 53 | Morphine addiction_Homo sapiens_hsa05032 | 1.16606715 |
| 54 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.09512473 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08399392 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.08232717 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 1.07240101 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.07159518 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.03486382 |
| 60 | Nicotine addiction_Homo sapiens_hsa05033 | 1.02809774 |
| 61 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98634710 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98198255 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.98062425 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.96753110 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96620767 |
| 66 | Cocaine addiction_Homo sapiens_hsa05030 | 0.94770380 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94558192 |
| 68 | Huntingtons disease_Homo sapiens_hsa05016 | 0.93636488 |
| 69 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.90570339 |
| 70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90312291 |
| 71 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89964956 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89246435 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.89141184 |
| 74 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.88128614 |
| 75 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87534205 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84738704 |
| 77 | Circadian entrainment_Homo sapiens_hsa04713 | 0.84542948 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84426606 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81583432 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80979848 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.80952976 |
| 82 | Salivary secretion_Homo sapiens_hsa04970 | 0.80213588 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78759957 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.75941694 |
| 85 | Lysosome_Homo sapiens_hsa04142 | 0.75530504 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75292447 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75067066 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73322750 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73162625 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72924814 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71797367 |
| 92 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.71021563 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70501468 |
| 94 | Carbon metabolism_Homo sapiens_hsa01200 | 0.70346953 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.69530558 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.69394346 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.69200876 |
| 98 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.68359352 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68050318 |
| 100 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67472356 |
| 101 | Taste transduction_Homo sapiens_hsa04742 | 0.66370137 |
| 102 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.65194648 |
| 103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64423542 |
| 104 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.64296515 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63857544 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.61685328 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61157668 |
| 108 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60981069 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60620010 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59970459 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59389610 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58750088 |
| 113 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.57867294 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57416279 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.56199517 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55886484 |
| 117 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53770366 |
| 118 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.53545380 |
| 119 | Renin secretion_Homo sapiens_hsa04924 | 0.51423657 |
| 120 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51221656 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.50049235 |
| 122 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48415208 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47160264 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46816202 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.46622257 |
| 126 | Pertussis_Homo sapiens_hsa05133 | 0.46396501 |
| 127 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.46380710 |
| 128 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44911635 |
| 129 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44053155 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43425648 |
| 131 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42649064 |
| 132 | Asthma_Homo sapiens_hsa05310 | 0.42361359 |
| 133 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.42067531 |
| 134 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42039225 |
| 135 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41724211 |
| 136 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39013823 |
| 137 | Gap junction_Homo sapiens_hsa04540 | 0.38741032 |
| 138 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.38361082 |
| 139 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38111780 |
| 140 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36908080 |
| 141 | Insulin secretion_Homo sapiens_hsa04911 | 0.35628561 |
| 142 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35272194 |
| 143 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.34055647 |
| 144 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.33792035 |
| 145 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33326078 |
| 146 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32850459 |
| 147 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32439113 |
| 148 | Olfactory transduction_Homo sapiens_hsa04740 | 0.31984638 |
| 149 | Prion diseases_Homo sapiens_hsa05020 | 0.31450282 |
| 150 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30501129 |
| 151 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30396332 |
| 152 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30057330 |
| 153 | Peroxisome_Homo sapiens_hsa04146 | 0.29142739 |
| 154 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28896494 |
| 155 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28484321 |
| 156 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27917457 |
| 157 | Long-term potentiation_Homo sapiens_hsa04720 | 0.27737492 |
| 158 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.27551545 |
| 159 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.25697232 |
| 160 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.24872523 |

